El Referente – Medtech Company Thytech Raises €350,000 in Its First Investment Round
The deal was led by BStartup, Banco Sabadell’s startup investment unit, and will support the Gregorio Marañón Hospital spin-off in advancing its immune-regulation treatment. Thytech, a startup founded by researchers from the Hospital General Universitario Gregorio Marañón in Madrid, has just closed its first €350,000 funding round. The round was led by Banco Sabadell through […]
VIAempresa – Sabadell Leads Thytech’s First Investment Round
The Madrid-based medtech company Thytech has raised €350,000 to advance its cell therapy aimed at preventing transplant rejection. BStartup Health, the Banco Sabadell program dedicated to financing early-stage healthcare companies, has led the €350,000 funding round for Thytech, a company specialized in cell therapy. The round also included participation from Genesis Biomed and other private […]
El Plural – Banco Sabadell Leads the First Investment Round of Medtech Company Thytech
In the €350,000 funding round, participants included Banco Sabadell’s BStartup, Genesis Biomed, and private investors. A cell therapy designed to prevent transplant rejection, treat autoimmune diseases, and even reduce mortality in severe COVID-19 patients — this is the unique, world-first treatment developed by Thytech, a startup founded by researchers from Hospital General Universitario Gregorio Marañón. […]
Bolasamanía – Economy/Finance.- Banco Sabadell Leads the First €350,000 Investment Round of Medtech Company Thytech
Banco Sabadell has led the first investment round of medtech company Thytech, which closed at €350,000. This marks the second investment from the fourth edition of the BStartup Health program, which received applications from 121 startups. Thytech was founded by researchers from the Health Research Institute of Hospital Gregorio Marañón (IISGM) in Madrid and has […]
Treg Directed Therapies – Expand the Application of Treg Therapies into a Clinical Reality
Accelerate the Translation of Modulator & Treg Cell Therapies to Redefine Immune Tolerance for Autoimmune, Inflammatory, & Neurodegenerative Diseases With Nobel Prize recognition, clinical advances by Nektar Therapeutics and ORCA-T’s potential as the first FDA-approved Treg cell therapy, Treg therapies are making waves. At the 8th Treg-Directed Therapies Summit, Treg experts including Quell Therapeutics, Nektar Therapeutics, Sanofi, Yale and more, converge to overcome key challenges from cell targeting, Treg mechanisms of […]
El Confidencial – Gregorio Marañón Creates a Pioneering Treatment Against Transplant Rejection
A team of researchers at Hospital General Universitario Gregorio Marañón has developed a world-pioneering cell-based treatment to prevent transplant rejection. The technique is already being used to treat three infant heart transplant recipients, all of whom are progressing favorably. The treatment, developed entirely at this public hospital in Madrid over the past six years, helps […]
Madrid es Noticia – Gregorio Marañón Develops a Pioneering Treatment Against Transplant Rejection
A research team at Hospital General Universitario Gregorio Marañón has developed a world-pioneering cell-based treatment designed to prevent transplant rejection. The technique is already being used to treat three infant heart transplant recipients, all of whom are progressing favorably. The treatment, developed entirely at this public Madrid hospital over the past six years, helps prevent […]
Gaceta Médica – Marañón Discovers a World-Unique “Escape Route” Against Transplant Rejection
It is a cell therapy that “rescues” Treg cells from thymic tissue, helping to regulate the immune response in a sustained manner. Although organ transplantation is one of medicine’s greatest achievements and has saved thousands of lives, it is not a definitive solution because of immune rejection. As a result, most transplanted organs last fewer […]
20 minutos – Three Babies Receive Heart Transplants with a World-Pioneering Cell Therapy to Prevent Rejection
The transplant was performed at Hospital General Universitario Gregorio Marañón, making it a global pioneer. All three babies are evolving “favorably.” For the first time, thymus-derived Treg cells are being used, potentially prolonging the survival of the transplanted organ and the life of the patient. A team of researchers at Gregorio Marañón Hospital in the […]
Madridpress – Marañón Develops a Cell Therapy That Could Prevent Organ Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based treatment to prevent organ transplant rejection. According to the Madrid hospital’s scientists, the therapy may regulate the immune system’s response and prevent rejection. The treatment, the result of more than six years of research carried out entirely at Gregorio Marañón, could completely inhibit […]
